Furlan M, Leupin L, Biasiutti F D, Lämmle B
Hämatologisches Zentrallabor, Inselspital, Bern.
Schweiz Med Wochenschr. 1991 Jul 20;121(29):1068-71.
A heterozygous hereditary fibrinogen variant, fibrinogen Bern III, has been characterized. The proposita and her daughter showed prolonged thrombin time and reptilase time, as well as a markedly reduced fibrinogen concentration as determined by functional clotting assay. Fibrinogen was purified from the proposita's plasma and subjected to biochemical characterization. The delayed fibrin formation was shown to result from impaired release of fibrinopeptide A. Thrombin was found to cleave an extended fibrinopeptide A (A alpha 1-19) from the reduced polypeptide chains of the abnormal fibrinogen. Amino acid analysis of this fragment indicated that the arginine residue, located at the physiological thrombin cleavage site, was replaced by cysteine. The functional defect of the fibrinogen variant Bern III is due to the amino acid substitution A alpha 16 Arg----Cys.
一种杂合的遗传性纤维蛋白原变体,即纤维蛋白原伯尔尼III型,已得到鉴定。先证者及其女儿的凝血酶时间和爬虫酶时间延长,并且通过功能性凝血试验测定,纤维蛋白原浓度显著降低。从先证者血浆中纯化出纤维蛋白原,并进行生化鉴定。结果表明,纤维蛋白形成延迟是由于纤维蛋白肽A释放受损所致。发现凝血酶可从异常纤维蛋白原的还原多肽链上切割下一段延长的纤维蛋白肽A(Aα1-19)。对该片段的氨基酸分析表明,位于生理性凝血酶切割位点的精氨酸残基被半胱氨酸取代。纤维蛋白原变体伯尔尼III型的功能缺陷是由于氨基酸替换Aα16精氨酸→半胱氨酸所致。